TUBEROUS SCLEROSIS COMPLEX

Clinical trials for TUBEROUS SCLEROSIS COMPLEX explained in plain language.

Never miss a new study

Get alerted when new TUBEROUS SCLEROSIS COMPLEX trials appear

Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 7 Completed 4 Terminated 2

New daily pill aims to tame stubborn seizures in tuberous sclerosis

Disease control Not yet recruiting

This study tests an oral drug, AV078, in people aged 12 and older with tuberous sclerosis complex (TSC) whose seizures are not controlled by standard medications. Participants are randomly assigned to receive AV078 or a placebo for 12 weeks. The goal is to see if AV078 safely red…

Matched conditions: TUBEROUS SCLEROSIS COMPLEX

Phase: PHASE2 • Sponsor: Aeovian Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 04, 2026 00:00 UTC

TUBEROUS SCLEROSIS COMPLEX

Get alerted when new TUBEROUS SCLEROSIS COMPLEX trials appear

New daily pill aims to tame stubborn seizures in tuberous sclerosis